Video

Waqar Khan, MD: Coronary Heart Disease During COVID-19

Author(s):

Unhealthy lifestyles during the pandemic may increase the risk of cardiovascular disease.

The coronavirus disease 2019 (COVID-19) pandemic has been a perfect storm of factors that could increase the risk of coronary heart disease.

Many across the globe have been forced to give up their exercise regimen at gyms or sports leagues, lapsing on their exercise programs. Also there likely has been an increase in unhealthy eating, with a likelihood of snacking throughout the day and takeout food for meals.

Add those factors to an increase in stress and there might be a lasting impact of the global cardiovascular health.

In an interview with HCPLive®, Waqar Khan, MD, MPH, Founder and President of Lone Star Heart and Vascular Center, explained what some of the treatment gaps are in coronary heart disease and how the COVID-19 pandemic may have impacted cardiovascular health.

Khan recently published a new book called Be Heart Smart featuring real-life patient stories and evidence-based data to give a snapshot on the state of coronary heart disease.

Khan said most of the treatment gaps are in diagnosis, as well as finding a way to treat heart disease without needing to perform major bypasses and surgeries. He said there has been a push for more treatments that reduce these procedures and he expects even more in the future.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Discussing FDA Approval of Tapinarof Cream for Atopic Dermatitis, with John Browning, MD
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
© 2024 MJH Life Sciences

All rights reserved.